Search For "sars cov"
AI predicts which drug combinations kill cancer cells
Updated : 5 years, 3 months ago IST
Espoo [Finland], December 1 (ANI): A team of researchers have developed a machine learning model that accurately predicts how combinations of different cancer drugs kill various types of cancer cells. The new AI model was trained with a large set of data obtained from previous studies, which
Read More
FIZ researches on Kabasura Kudineer Tablets from Sri Sri Tattva, a classic
Updated : 5 years, 3 months ago IST
Bengaluru (Karnataka) [India], December 1 (ANI/NewsVoir): Global spiritual leader and humanitarian, Gurudev Sri Sri Ravi Shankar called for large scale studies on effectiveness of AYUSH medicines in tackling COVID-19 through immunity building after reported success in initial researches, inc
Read More
Highly effective measles virus-based Th1-biased coronavirus vaccine
Updated : 5 years, 3 months ago IST
Washington [US], December 1 (ANI): A measles-virus-based COVID-19 vaccine might be able to prevent both COVID-19 and measles, according to a new study.
Read More
COVID-19 studies should also focus on mucosal immunity, researchers argue
Updated : 5 years, 3 months ago IST
Washington [US], November 30 (ANI): University at Buffalo researchers argue in a new paper, more COVID-19 studies should be devoted to how immunity emerges to SARS-CoV-2 in the mucous membranes of the nose and mouth.
Read More
Researchers find genetic variations linked to COVID-19 severity
Updated : 5 years, 3 months ago IST
Boston (Massachusetts) [US], November 29 (ANI): A new study led by researchers from Beth Israel Deaconess Medical Center (BIDMC) sheds light on the genetic risk factors that make individuals more or less susceptible to severe COVID-19.
Read More
Bariatric surgery may reduce severity of coronavirus in obese patients
Updated : 5 years, 3 months ago IST
Washington [US], November 28 (ANI): Among obese patients who tested positive for COVID-19, a past history of bariatric surgery was significantly associated with a lower risk of hospital and intensive care unit admission, reveals Cleveland clinic study.
Read More
Genus Apparels launches G99 mask which destroys 99.99 percent coronavirus
Updated : 5 years, 3 months ago IST
New Delhi [India], November 26 (ANI/BusinessWire India): New Delhi-based manufacturer and exporter, Genus Apparels launches Genus G99 mask which destroys 99.99 per cent Coronavirus, accredited by a USA ISO certified laboratory.
Read More
Research shows bariatric surgery may reduce severity of COVID-19 in patien
Updated : 5 years, 3 months ago IST
Washington [US], November 25 (ANI): A Cleveland Clinic study shows that among patients who have obesity and who tested positive for COVID-19, a past history of bariatric surgery was significantly associated with a lower risk of hospital and intensive care unit admission.
Read More
Three drugs identified as possible therapeutics for Covid-19 by UTHSC rese
Updated : 5 years, 3 months ago IST
Washington [US], November 22(ANI): In recent research, scientists have identified three drugs as promising therapeutics for the COVID-19, the illness caused by the SARS-CoV-2 virus in its early stages.
Read More
AYUSH - DBT Collaboration takes Scientific Research into Covid 19 to advan
Updated : 5 years, 3 months ago IST
New Delhi [India], November 21 (ANI): The first animal study in India on SARS-CoV-2 virus (the cause of Covid-19), which arose out of collaboration between the Ministry of AYUSH and Department of Bio-Technology (DBT) has moved into its final stages, the Government of India said on Friday.
Read More
UTHSC researchers identify three drugs as possible therapeutics for Covid-
Updated : 5 years, 3 months ago IST
Washington [US], November 19 (ANI): Three drugs, already approved for other uses in humans, have been identified as possible therapeutics for COVID-19, the illness caused by the SARS-CoV-2 virus.
Read More
Study focuses on identification of SARS-CoV-2 virus features causing COVID
Updated : 5 years, 4 months ago IST
Seoul [South Korea], November 15 (ANI): Features of the SARS-CoV-2 virus causing COVID-19, which could be useful for developing vaccines and treatment strategies, were identified using a nonhuman primate model developed at the Korea Research Institute of Bioscience and Biotechnology (KRIBB).
Read More